北京中医药2025，Vol.44Issue(8)：992-996,5.DOI:10.16025/j.1674-1307.2025.08.009
疏肝止眩饮治疗原发性后半规管良性阵发性位置性眩晕复位后残余头晕(肝郁脾虚证)疗效观察
Clinical efficacy of Shugan Zhixuan Decoction in the treatment of residual dizziness(liver depression and spleen deficiency syndrome)of primary posterior semicircular canal BPPV after reposition
摘要
Abstract
Objective To observe the efficacy of Shugan Zhixuan Decoction in treating residual dizziness(liver depression and spleen deficiency syndrome)after reposition in patients with primary posterior semicircular canal benign paroxysmal positional vertigo(BPPV).Methods A total of 80 patients with primary posterior semicircular canal BPPV and residual dizziness(liver depression and spleen deficiency syndrome)who were diagnosed at the Vestibular Center,Department of Otorhinolaryngology,Dongfang Hospital,Beijing University of Chinese Medicine from June 2022 to March 2023 were selected.These patients were randomly divided into the observation group and the control group using a random number table.The observation group received Shugan Zhixuan Decoction granules,while the control group received a placebo simulating Shugan Zhixuan Decoction.Both groups were administered 1 packet per dose,twice a day,dissolved in 50-100 mL of warm water,for 14 consecutive days.Before and after treatment,the traditional Chinese medicine(TCM)dizziness syndrome scale score and therapeutic effect were compared between the two groups.Additionally,the Modified Clinical Test of Sensory Interaction on Balance(mCTSIB)was used to measure static postural sway under four conditions[eyes open on firm surface(Firm-EO),eyes closed on firm surface(Firm-EC),eyes open on foam surface(Foam-EO),and eyes closed on foam surface(Foam-EC)].The swaying velocity was compared.The Dizziness Handicap Inventory(DHI)scores were also compared.Results After treatment,both groups showed a significant decrease in TCM dizziness syndrome scale scores compared to baseline(P<0.05).The observation group had lower TCM dizziness syndrome scale scores than the control group(P<0.05).The total effective rate in the observation group was 91.67%,significantly higher than 73.68%in the control group(P<0.05).After treatment,the sway velocity under Foam-EO and Foam-EC conditions decreased in both groups compared to baseline(P<0.05),with the observation group showing a lower sway velocity than the control group(P<0.05).The DHI scores for both groups decreased significantly after treatment(P<0.05),with the observation group having lower DHI scores than the control group(P<0.05).Conclusion Shugan Zhixuan Decoction can effectively improve residual dizziness symptoms after reposition in primary posterior semicircular canal BPPV,with significant therapeutic efficacy.关键词
良性阵发性位置性眩晕/残余头晕/肝郁脾虚证/疏肝止眩饮Key words
benign paroxysmal positional vertigo/residual dizziness/liver depression and spleen deficiency syndrome/Shugan Zhixuan Decoction引用本文复制引用
高天凤,吴文丽,刘大新,丁雷..疏肝止眩饮治疗原发性后半规管良性阵发性位置性眩晕复位后残余头晕(肝郁脾虚证)疗效观察[J].北京中医药,2025,44(8):992-996,5.基金项目
首都卫生发展科研专项(2024-2-4204) （2024-2-4204）
